{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T19:10:12Z","timestamp":1774120212747,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2000,1,1]],"date-time":"2000-01-01T00:00:00Z","timestamp":946684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":5819,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2000,1]]},"DOI":"10.1046\/j.1523-1755.2000.00819.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T09:32:45Z","timestamp":1047461565000},"page":"282-292","source":"Crossref","is-referenced-by-count":71,"title":["Comparison of treatments for mild secondary hyperparathyroidism in hemodialysis patients"],"prefix":"10.1016","volume":"57","author":[{"given":"Olafur S.","family":"Indridason","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. Darryl","family":"Quarles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"for the Durham Renal Osteodystrophy Study Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1046\/j.1523-1755.2000.00819.x_bb0010","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/S0272-6386(97)90459-5","article-title":"Hyperparathyroidism in the hemodialysis population: A survey of 612 patients","volume":"29","author":"Salem","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1046\/j.1523-1755.2000.00819.x_bb0015","doi-asserted-by":"crossref","first-page":"357","DOI":"10.7326\/0003-4819-78-3-357","article-title":"Skeletal resistance to parathyroid hormone in renal failure: Studies in 105 human subjects","volume":"78","author":"Massry","year":"1973","journal-title":"Ann Intern Med"},{"key":"10.1046\/j.1523-1755.2000.00819.x_bb0020","first-page":"145","article-title":"Intact parathyroid hormone overestimates the presence and severity of parathyroid-mediated osseous abnormalities in uremia","volume":"75","author":"Quarles","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1046\/j.1523-1755.2000.00819.x_bb0025","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/0272-6386(95)90599-5","article-title":"Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis","volume":"26","author":"Qi","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.1046\/j.1523-1755.2000.00819.x_bb0030","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/ki.1994.31","article-title":"Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD\/CCPD","volume":"45","author":"Salusky","year":"1994","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2000.00819.x_bb0035","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/0272-6386(95)90453-0","article-title":"PEI: Relationship between intact 1-84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicity","volume":"26","author":"Wang","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.1046\/j.1523-1755.2000.00819.x_bb0040","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1038\/ki.1994.223","article-title":"Prospective trial of pulse oral versus intravenous calcitriol treatment of hyperparathyroidism in ESRD","volume":"45","author":"Quarles","year":"1994","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2000.00819.x_bb0045","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/ki.1994.380","article-title":"Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy","volume":"46","author":"Goodman","year":"1994","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2000.00819.x_bb0050","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/ki.1989.89","article-title":"1,25(OH)2 vitamin D3 inhibits parathyroid cell proliferation in experimental uremia","volume":"35","author":"Szabo","year":"1989","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2000.00819.x_bb0055","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1038\/ki.1993.377","article-title":"Intermittent versus continuous administration of 1,25-dihydroxyvitamin D3 in experimental renal hyperparathyroidism","volume":"44","author":"Reichel","year":"1993","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2000.00819.x_bb0060","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/ki.1989.277","article-title":"Long-term effects of calcium carbonate and 2.5 mEq\/liter calcium dialysate on mineral metabolism","volume":"36","author":"Slatopolsky","year":"1989","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2000.00819.x_bb0065","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1159\/000187515","article-title":"Oral calcium effectively reduces parathyroid hormone levels in hemodialysis patients: A randomized double-blind placebo-controlled study","volume":"65","author":"Rudnicki","year":"1993","journal-title":"Nephron"},{"key":"10.1046\/j.1523-1755.2000.00819.x_bb0070","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/ki.1988.258","article-title":"Oral calcitriol and calcium: Efficient therapy for uremic hyperparathyroidism","volume":"34","author":"Quarles","year":"1988","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2000.00819.x_bb0075","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0272-6386(12)80955-3","article-title":"Reduced risk of hypercalcemia for hemodialysis patients by administering calcitriol at night","volume":"19","author":"Schaefer","year":"1992","journal-title":"Am J Kidney Dis"},{"key":"10.1046\/j.1523-1755.2000.00819.x_bb0080","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0009-9120(97)00113-6","article-title":"Biochemical markers of bone metabolism: An overview","volume":"30","author":"Christenson","year":"1997","journal-title":"Clin Biochem"},{"key":"10.1046\/j.1523-1755.2000.00819.x_bb0085","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1681\/ASN.V73506","article-title":"Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients","volume":"7","author":"Urena","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"10.1046\/j.1523-1755.2000.00819.x_bb0090","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1093\/oxfordjournals.ndt.a027457","article-title":"Low serum levels of alkaline phosphatase of bone origin: A good marker of adynamic bone disease in haemodialysis patients","volume":"11","author":"Couttenye","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1046\/j.1523-1755.2000.00819.x_bb0095","first-page":"51","article-title":"Can low-dosage aluminium hydroxide control the plasma phosphate without bone toxicity?","volume":"4","author":"Jenkins","year":"1989","journal-title":"Nephrol Dial Transplant"},{"key":"10.1046\/j.1523-1755.2000.00819.x_bb0100","first-page":"97","article-title":"Comparative effect of oral or intravenous calcitriol on secondary hyperparathyroidism in chronic hemodialysis patients","volume":"20","author":"Liou","year":"1994","journal-title":"Miner Electrolyte Metab"},{"key":"10.1046\/j.1523-1755.2000.00819.x_bb0105","first-page":"216","article-title":"Comparison of intermittent oral and intravenous calcitriol in hemodialysis patients with secondary hyperparathyroidism","volume":"40","author":"Fischer","year":"1993","journal-title":"Clin Nephrol"},{"key":"10.1046\/j.1523-1755.2000.00819.x_bb0110","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00041552-199507000-00004","article-title":"Oral versus intravenous calcitriol: Is the route of administration really important? (review)","volume":"4","author":"Indridason","year":"1995","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1046\/j.1523-1755.2000.00819.x_bb0115","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1093\/oxfordjournals.ndt.a027665","article-title":"A direct effect in vitro of phosphate on PTH release from bovine parathyroid tissue slices but not from dispersed parathyroid cells","volume":"11","author":"Nielsen","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1046\/j.1523-1755.2000.00819.x_bb0120","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1172\/JCI118224","article-title":"Parathyroid cell proliferation in normal and chronic renal failure rats: The effects of calcium, phosphate, and vitamin D","volume":"96","author":"Naveh-Many","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1046\/j.1523-1755.2000.00819.x_bb0125","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/ki.1991.314","article-title":"Calcemic response to parathyroid hormone in renal failure: Role of phosphorus and its effect on calcitriol","volume":"40","author":"Rodriguez","year":"1991","journal-title":"Kidney Int"},{"issue":"Suppl","key":"10.1046\/j.1523-1755.2000.00819.x_bb0130","first-page":"S135","article-title":"Skeletal response to intermittent calcitriol therapy in secondary hyperparathyroidism","volume":"53","author":"Salusky","year":"1996","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2000.00819.x_bb0135","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1093\/ndt\/13.9.2294","article-title":"Bone markers in the diagnosis of low turnover osteodystrophy in haemodialysis patients","volume":"13","author":"Coen","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1046\/j.1523-1755.2000.00819.x_bb0140","first-page":"1320","article-title":"Alkaline phosphatase of bone origin in hemodialyzed patients: 110 assays","volume":"25","author":"Urena","year":"1996","journal-title":"Presse Med"},{"key":"10.1046\/j.1523-1755.2000.00819.x_bb0145","series-title":"Renal Osteodystrophy","first-page":"445","article-title":"Prevention and management of renal osteodystrophy in dialysis patients,","author":"Indridason","year":"1997"},{"key":"10.1046\/j.1523-1755.2000.00819.x_bb0150","first-page":"307","article-title":"Aluminum-related osteodystrophy","volume":"34","author":"Sherrard","year":"1989","journal-title":"Adv Intern Med"},{"key":"10.1046\/j.1523-1755.2000.00819.x_bb0155","first-page":"90","article-title":"Aluminum: Culprit or accessory in the genesis of renal osteodystrophy","volume":"6","author":"Quarles","year":"1986","journal-title":"Semin Nephrol"},{"key":"10.1046\/j.1523-1755.2000.00819.x_bb0160","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1046\/j.1523-1755.1999.00432.x","article-title":"Aluminum is a weak agonist for the calcium-sensing receptor","volume":"55","author":"Spurney","year":"1999","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2000.00819.x_bb0165","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1056\/NEJM199102213240804","article-title":"Aluminum accumulation during treatment with aluminum hydroxide and dialysis in children and young adults with chronic renal disease","volume":"324","author":"Salusky","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1523-1755.2000.00819.x_bb0170","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1001\/jama.1972.03210130032008","article-title":"Uremic osteodystrophy: The therapeutic consequences of effective control of serum phosphorus","volume":"222","author":"Pinggera","year":"1972","journal-title":"JAMA"},{"key":"10.1046\/j.1523-1755.2000.00819.x_bb0175","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","article-title":"Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study","volume":"31","author":"Block","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1046\/j.1523-1755.2000.00819.x_bb0180","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/ki.1996.22","article-title":"Magnesium carbonate as a phosphorus binder: A prospective, controlled, crossover study","volume":"49","author":"Delmez","year":"1996","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2000.00819.x_bb0185","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0272-6386(97)90009-3","article-title":"Poly[allylamine hydrochloride] (RenaGel): A noncalcemic phosphate binder for the treatment of hyperphosphatemia in chronic renal failure","volume":"29","author":"Chertow","year":"1997","journal-title":"J Kidney Dis"},{"key":"10.1046\/j.1523-1755.2000.00819.x_bb0190","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/ki.1997.39","article-title":"Effective suppression of parathyroid hormone by 1 alpha-hydroxy-vitamin D2 in hemodialysis patients with moderate to severe secondary hyperparathyroidism","volume":"51","author":"Tan","year":"1997","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2000.00819.x_bb0195","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1681\/ASN.V981427","article-title":"19-Nor-1-alpha-25-dihyrdoxyvitamin D-2 (paricalcitol) safely and effectively reduces the levels of intact parathyroid hormone in patients on hemodialysis","volume":"9","author":"Martin","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1046\/j.1523-1755.2000.00819.x_bb0200","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1046\/j.1523-1755.1998.00735.x","article-title":"A calcimimetic agent acutely suppresses parathyroid hormone levels in patients with chronic renal failure","volume":"53","author":"Antonsen","year":"1998","journal-title":"Kidney Int"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815467286?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815467286?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T16:31:56Z","timestamp":1648830716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815467286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,1]]}},"alternative-id":["S0085253815467286"],"URL":"https:\/\/doi.org\/10.1046\/j.1523-1755.2000.00819.x","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2000,1]]}}}